1999
DOI: 10.1016/s0890-6238(99)00002-7
|View full text |Cite
|
Sign up to set email alerts
|

Developmental toxicity of di-isodecyl and di-isononyl phthalates in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
20
0
1

Year Published

2001
2001
2023
2023

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 54 publications
(21 citation statements)
references
References 18 publications
0
20
0
1
Order By: Relevance
“…For example, peroxisome proliferation, a likely mode of action for liver tumors in mice, was not observed when DiNP was administered by gavage to monkeys (Pugh et al 2000;Hall et al 1999). DiNP also caused skeletal and urinary system developmental toxicity in rats exposed prenatally to DiNP at maternally toxic doses (Hellwig et al 1997;Waterman et al 1999). Studies of fetal testicular testosterone production and other reproductive endpoints from prenatal DiNP exposure in rats have produced conflicting results, possibly due to experimental differences in the route, timing, and levels of dosing (Boberg et al 2011;Adamsson et al 2009;Borch et al 2004;Masutomi et al 2003;Waterman et al 2000;Gray et al 2000).…”
Section: Introductionmentioning
confidence: 99%
“…For example, peroxisome proliferation, a likely mode of action for liver tumors in mice, was not observed when DiNP was administered by gavage to monkeys (Pugh et al 2000;Hall et al 1999). DiNP also caused skeletal and urinary system developmental toxicity in rats exposed prenatally to DiNP at maternally toxic doses (Hellwig et al 1997;Waterman et al 1999). Studies of fetal testicular testosterone production and other reproductive endpoints from prenatal DiNP exposure in rats have produced conflicting results, possibly due to experimental differences in the route, timing, and levels of dosing (Boberg et al 2011;Adamsson et al 2009;Borch et al 2004;Masutomi et al 2003;Waterman et al 2000;Gray et al 2000).…”
Section: Introductionmentioning
confidence: 99%
“…47) A combination of di erent analytical technologies and data mining tools is needed to e ciently and thoroughly identify metabolites for discovering the biomarkers of exposure, toxic e ects, or diseases. To achieve that, IPF is a stable isotope-based metabolomics approach using compound labeled with 2 H, 13 C, 15 N, or 18 O that can be used to facilitate identi cation of the metabolites. 42,48,49) e stable isotope ratio (1 : 1) from spiked native and isotope-labeled compounds were used for metabolite signal detection.…”
Section: Methods Of Mass Spectrometry In Dis-covery Of Exposure Markermentioning
confidence: 99%
“…14) Skin may come into direct contact with phthalate-containing products. 15) Phthalates such as di-n-butyl phthalate (DBP) and di-(2-ethylhexyl)phthalate (DEHP) are endocrine disruptors and may a ect reproductive outcomes, the development of the male reproductive tract, [16][17][18] and sexual di erentiation in male rats. 16,19,20) Epidemiological studies have also revealed that exposure to several commonly used phthalates such as DBP and DHEP can alter sex steroid hormone levels in human subjects.…”
Section: Phthalates and Toxicological Infor-mationmentioning
confidence: 99%
“…It appears that liver and kidney tumors induced by DiDP are the result of non-genotoxic processes (McKee et al, 2000). In some animal studies, prenatal developmental and reproductive toxicity of DiDP were also reported (Hellwig et al, 1997;Hushka et al, 2001;Kavlock et al, 2002;Waterman et al, 1999).…”
Section: Introductionmentioning
confidence: 98%